Rare diseases
Investigational molecules
Locations
Autonomia Etorbidea 10, 48940 Leioa, Spain
Faes Farma S.A. supports clinical research in ulcerative colitis and chronic idiopathic inflammatory bowel disease, with attention to symptoms, intestinal inflammation, and remission outcomes in patients with active disease.
The sponsor’s gastrointestinal portfolio also includes studies in oral mesalazine formulations and their use in controlling disease activity.
Faes Farma S.A. runs clinical trials in conditions such as Conjunctivitis allergic, Hypersensitivity, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
ItalySpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
